Hypo fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer: A Phase II Comparative Study of PSA Kinetics, Dosimetric and Toxicity Outcomes
{{output}}
Background: Prostate cancer (PCa) is a leading global malignancy, with unfavorable intermediate‑risk (UIR) and high‑risk (HR) disease requiring optimized treatment strategies. Hypo fractionated intensity‑modulated radiotherapy... ...
